Minimally Invasive Robot-assisted and Laparoscopic Distal Pancreatectomy in a Pan-European Registry
1 other identifier
observational
1,672
1 country
1
Brief Summary
A planned analysis of outcomes among consecutive patients after MIDP from centers participating in the E-MIPS registry (2019-2021). Main outcomes of interest were intraoperative events, major morbidity (Clavien-Dindo grade ≥3) and 30-day/in-hospital mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
November 29, 2023
CompletedFirst Posted
Study publicly available on registry
December 7, 2023
CompletedDecember 7, 2023
November 1, 2023
3 years
November 29, 2023
November 29, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Intraoperative events
Major bleeding or change in operation
30 days
30-day/in-hospital mortality.
Dead in hospital or within 30 days
30 days
Interventions
all patients undergoing minimally invasive distal pancreatectomy, no intervention, no randomization
Eligibility Criteria
Patients who underwent laparoscopic or robotic distal pancreatecromy between January 1st 2019 and December 31st 2021
You may qualify if:
- Data from all patients who underwent laparoscopic or robotic distal pancreatecromy between January 1st 2019 and December 31st 2021 were included
You may not qualify if:
- Other pancreatic procedures Hybrid approaches (reconstruction phase open) Procedures with insufficient baseline data / missing primary outcome data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Amsterdam UMC, locatie AMC
Amsterdam, North Holland, 1105 AZ, Netherlands
Related Publications (1)
van Bodegraven EA, van Ramshorst TME, Bratlie SO, Kokkola A, Sparrelid E, Bjornsson B, Kleive D, Burgdorf SK, Dokmak S, Groot Koerkamp B, Cabus SS, Molenaar IQ, Boggi U, Busch OR, Petric M, Roeyen G, Hackert T, Lips DJ, D'Hondt M, Coolsen MME, Ferrari G, Tingstedt B, Serrablo A, Gaujoux S, Ramera M, Khatkov I, Ausania F, Souche R, Festen S, Berrevoet F, Keck T, Sutcliffe RP, Pando E, de Wilde RF, Aussilhou B, Krohn PS, Edwin B, Sandstrom P, Gilg S, Seppanen H, Vilhav C, Abu Hilal M, Besselink MG; European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS). Minimally invasive robot-assisted and laparoscopic distal pancreatectomy in a pan-European registry a retrospective cohort study. Int J Surg. 2024 Jun 1;110(6):3554-3561. doi: 10.1097/JS9.0000000000001315.
PMID: 38498397DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of HPB Surgery
Study Record Dates
First Submitted
November 29, 2023
First Posted
December 7, 2023
Study Start
January 1, 2019
Primary Completion
December 31, 2021
Study Completion
January 1, 2022
Last Updated
December 7, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share